Top Markets
Coin of the day
VISEN Pharmaceuticals VISEN Pharmaceuticals

VISEN Pharmaceuticals

2561
Rang în acțiuni #16737
VISEN Pharmaceuticals operates as an investment holding company, concentrating... VISEN Pharmaceuticals operates as an investment holding company, concentrating on the development and commercialization of endocrine treatments across mainland China, Hong Kong, and Taiwan. Their flagship product, Lonapegsomatropin, offers a once-weekly, long-acting growth hormone replacement designed for pediatric growth hormone deficiency. The company is also progressing other therapies, such as TransCon CNP (navepegritide), a long-acting prodrug utilizing c-type natriuretic peptide for achondroplasia, and Palopegteriparatide, a daily parathyroid hormone replacement therapy intended for chronic hypoparathyroidism. VISEN has forged strategic collaborations with Shanghai Pharmaceutical and United Family Healthcare. The enterprise was founded in 2018 and is based in Suzhou, China.
Preț acțiune
$2.47
Capitalizare de piață
$269.48M
Schimbare (1 zi)
-1.43%
Schimbare (1 an)
-56.93%
Țară
CN
Tranzacționează VISEN Pharmaceuticals (2561)

Categorie

Prețul 2561 cu capitalizarea de piață a B
VISEN Pharmaceuticals VISEN Pharmaceuticals
2561
$2.47
Capitalizarea de piață a VISEN Pharmaceuticals(2561)
Capitalizare de piață: $269.48M
În anul September 2026, VISEN Pharmaceuticals are o capitalizare de piață de $269.48M. Acest lucru face ca VISEN Pharmaceuticals să fie a 16737th-a cea mai valoroasă companie din lume, conform datelor noastre. Capitalizarea bursieră reprezintă valoarea totală de piață a acțiunilor în circulație ale unei companii listate și este utilizată frecvent pentru a măsura valoarea unei companii.
Istoricul capitalizării de piață a VISEN Pharmaceuticals din 2025 până în 2026
2561 în comparație cu top 5 cele mai populare stocks
Prețul pentru 2561 Activul B Capitalizarea de piață a B Rezultate
VISEN Pharmaceuticals VISEN Pharmaceuticals
$48,237.65 $269.48M
$5.260T +1,951,628.50%
VISEN Pharmaceuticals VISEN Pharmaceuticals
$43,825.52 $269.48M
$4.779T +1,773,110.67%
VISEN Pharmaceuticals VISEN Pharmaceuticals
$36,838.88 $269.48M
$4.017T +1,490,426.57%
VISEN Pharmaceuticals VISEN Pharmaceuticals
$34,111.04 $269.48M
$3.719T +1,380,056.11%
VISEN Pharmaceuticals VISEN Pharmaceuticals
$25,076.63 $269.48M
$2.734T +1,014,517.80%